UBS Raises Price Target on Quest Diagnostics (DGX) to $102; Reiterates Buy
Tweet Send to a Friend
UBS reiterated a Buy rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $102.00 (from $90.00). Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
